|
|
Volumn 27, Issue 8, 2005, Pages 399-405
|
|
Clinical use of a haemoglobin-based oxygen-carrying solution in dogs and cats
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANEMIC AGENT;
CORTICOSTEROID;
HEMOGLOBIN DERIVATIVE;
HETASTARCH;
METHEMOGLOBIN;
OXYGEN;
OXYGLOBIN;
ANEMIA;
ARTICLE;
BLOOD OXYGEN TENSION;
CARDIOVASCULAR DISEASE;
CAT DISEASE;
CLINICAL TRIAL;
CRYSTALLOID;
DISEASE TRANSMISSION;
DOG DISEASE;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG ELIMINATION;
DRUG FATALITY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG METABOLISM;
DRUG PACKAGING;
DRUG SOLUTION;
DRUG STABILITY;
DRUG SYNTHESIS;
ERYTHROCYTE TRANSFUSION;
GASTROINTESTINAL SYMPTOM;
HEMATOCRIT;
HEMOGLOBIN DETERMINATION;
HEMORRHAGIC SHOCK;
HUMAN;
HYPERTENSION;
HYPOVOLEMIC SHOCK;
LICENCE;
NEPHROTOXICITY;
NONHUMAN;
OXYGEN DISSOCIATION CURVE;
RESPIRATORY TRACT DISEASE;
UNITED KINGDOM;
URINE COLOR;
VASCULAR RESISTANCE;
CANIS FAMILIARIS;
|
|
EID: 24944523400
PISSN: 0263841X
EISSN: 20427689
Source Type: Journal
DOI: 10.1136/inpract.27.8.399 Document Type: Article |
|
Times cited : (11)
|
|
References (3)
|
